1. Home
  2. MDGL vs CMC Comparison

MDGL vs CMC Comparison

Compare MDGL & CMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • CMC
  • Stock Information
  • Founded
  • MDGL 2011
  • CMC 1915
  • Country
  • MDGL United States
  • CMC United States
  • Employees
  • MDGL N/A
  • CMC N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • CMC Steel/Iron Ore
  • Sector
  • MDGL Health Care
  • CMC Industrials
  • Exchange
  • MDGL Nasdaq
  • CMC Nasdaq
  • Market Cap
  • MDGL 6.1B
  • CMC 5.5B
  • IPO Year
  • MDGL N/A
  • CMC 1987
  • Fundamental
  • Price
  • MDGL $304.86
  • CMC $49.12
  • Analyst Decision
  • MDGL Strong Buy
  • CMC Buy
  • Analyst Count
  • MDGL 9
  • CMC 8
  • Target Price
  • MDGL $420.63
  • CMC $59.93
  • AVG Volume (30 Days)
  • MDGL 305.4K
  • CMC 1.3M
  • Earning Date
  • MDGL 08-06-2025
  • CMC 06-23-2025
  • Dividend Yield
  • MDGL N/A
  • CMC 1.44%
  • EPS Growth
  • MDGL N/A
  • CMC N/A
  • EPS
  • MDGL N/A
  • CMC 0.32
  • Revenue
  • MDGL $317,383,000.00
  • CMC $7,680,111,000.00
  • Revenue This Year
  • MDGL $286.17
  • CMC N/A
  • Revenue Next Year
  • MDGL $64.17
  • CMC $8.14
  • P/E Ratio
  • MDGL N/A
  • CMC $158.73
  • Revenue Growth
  • MDGL N/A
  • CMC N/A
  • 52 Week Low
  • MDGL $200.63
  • CMC $37.92
  • 52 Week High
  • MDGL $377.46
  • CMC $64.53
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 61.70
  • CMC 58.68
  • Support Level
  • MDGL $277.64
  • CMC $49.03
  • Resistance Level
  • MDGL $314.22
  • CMC $50.47
  • Average True Range (ATR)
  • MDGL 11.62
  • CMC 1.26
  • MACD
  • MDGL 3.11
  • CMC -0.02
  • Stochastic Oscillator
  • MDGL 82.64
  • CMC 66.74

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About CMC Commercial Metals Company

Commercial Metals Co operates steel mills, steel fabrication plants, and metal recycling facilities in the United States and manufactures rebar and structural steel, which are key product categories for the nonresidential construction sector. The Company has three operating and reportable segments: North America Steel Group, Europe Steel Group and Emerging Businesses Group.

Share on Social Networks: